Učitavanje...
Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology
One distinct molecular subtype of non-small cell lung cancer (NSCLC) is defined by rearrangement of the anaplastic lymphoma kinase (ALK). The increasing knowledge over the last years has enabled the continuous improvement of ALK inhibitors; however, resistance in these patients remains a major conce...
Spremljeno u:
| Izdano u: | J Thorac Dis |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AME Publishing Company
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6353748/ https://ncbi.nlm.nih.gov/pubmed/30775023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.12.03 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|